Compare Merck Tbk. (MERK) vs Paramita Bangun Sarana Tbk. (PBSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Paramita Bangun Sarana Tbk. — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Paramita Bangun Sarana Tbk. trades at Rp750 (market cap 2.28T, 994K 24h volume). The key difference: Paramita Bangun Sarana Tbk. is the larger of the two by market cap, and Paramita Bangun Sarana Tbk. is more actively traded (994K versus 63K). Which is the better fit depends on your goals.
| MERK | PBSA | |
|---|---|---|
Market Cap | 1.76T | 2.28T |
Volume | 63K | 994K |
Lot | 630 | 9.94K |
Turnover | 243.97M | 754.23M |
Average Price | 3,872.46 | 758.78 |
Value | 243.97M | 754.23M |
Indicative Equilibrium Price | 3,900 | 750 |
Indicative Equilibrium Volume | 1 | 56 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →About Paramita Bangun Sarana Tbk.
PT. Paramita Bangun Sarana Tbk (the Company) was established based on the Notarial Deed No. 33 of Lenny Janis Ishak, S.H., dated November 27, 2002.
Read more on PBSA →
